Literature DB >> 11297744

CCAAT/enhancer-binding protein beta is required for activation of genes for ornithine cycle enzymes by glucocorticoids and glucagon in primary-cultured hepatocytes.

T Kimura1, S Chowdhury, T Tanaka, A Shimizu, K Iwase, S Oyadomari, T Gotoh, H Matsuzaki, M Mori, S Akira, M Takiguchi.   

Abstract

Transcription of genes for enzymes of the ornithine cycle is activated by hormones such as glucocorticoids and glucagon. Promoters and enhancers of several genes for the enzymes interact with the CCAAT/enhancer-binding protein (C/EBP) family of transcription factors, and C/EBPbeta has been suggested to mediate glucocorticoid response of the gene for arginase, the last enzyme of the cycle. To determine the contribution of C/EBPbeta to hormonal regulation of genes for ornithine cycle enzymes, we examined mice with targeted disruption of the C/EBPbeta gene. Induction of genes for the enzymes by intraperitoneal injection of dexamethasone and glucagon was almost intact in the liver of C/EBPbeta-deficient mice. On the other hand, in primary-cultured hepatocytes derived from C/EBPbeta-deficient mice, induction of genes for the first enzyme carbamylphosphate synthetase, as well as for arginase, in response to dexamethasone and/or glucagon was severely impaired. Therefore, C/EBPbeta is required for hormonal induction of the genes for ornithine cycle enzymes in primary-cultured hepatocytes, while the deficiency of C/EBPbeta is compensated for in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11297744     DOI: 10.1016/s0014-5793(01)02320-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Dexamethasone-induced up-regulation of the human norepinephrine transporter involves the glucocorticoid receptor and increased binding of C/EBP-β to the proximal promoter of norepinephrine transporter.

Authors:  Qinqin Zha; Yan Wang; Yan Fan; Meng-Yang Zhu
Journal:  J Neurochem       Date:  2011-09-28       Impact factor: 5.372

2.  What Are the bona fide GSK3 Substrates?

Authors:  Calum Sutherland
Journal:  Int J Alzheimers Dis       Date:  2011-05-18

3.  Corticosteroids induce COX-2 expression in cardiomyocytes: role of glucocorticoid receptor and C/EBP-beta.

Authors:  Haipeng Sun; Elena Sheveleva; Beibei Xu; Hiroyasu Inoue; Tim G Bowden; Qin M Chen
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-23       Impact factor: 4.249

Review 4.  The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights.

Authors:  Agnes E Coutinho; Karen E Chapman
Journal:  Mol Cell Endocrinol       Date:  2010-04-14       Impact factor: 4.102

5.  Transcriptional regulation of N-acetylglutamate synthase.

Authors:  Sandra Kirsch Heibel; Giselle Yvette Lopez; Maria Panglao; Sonal Sodha; Leonardo Mariño-Ramírez; Mendel Tuchman; Ljubica Caldovic
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

Review 6.  Ornithine Aminotransferase, an Important Glutamate-Metabolizing Enzyme at the Crossroads of Multiple Metabolic Pathways.

Authors:  Antonin Ginguay; Luc Cynober; Emmanuel Curis; Ioannis Nicolis
Journal:  Biology (Basel)       Date:  2017-03-07

7.  Proteomics-Based Identification of Interaction Partners of the Xenobiotic Detoxification Enzyme FMO3 Reveals Involvement in Urea Cycle.

Authors:  Zhao Yang; Paul M Stemmer; Michael C Petriello
Journal:  Toxics       Date:  2022-01-28

8.  Molecular regulation of urea cycle function by the liver glucocorticoid receptor.

Authors:  Jürgen G Okun; Sean Conway; Kathrin V Schmidt; Jonas Schumacher; Xiaoyue Wang; Roldan de Guia; Annika Zota; Johanna Klement; Oksana Seibert; Achim Peters; Adriano Maida; Stephan Herzig; Adam J Rose
Journal:  Mol Metab       Date:  2015-07-30       Impact factor: 7.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.